Tag:
rolapitant
Latest Headlines
Latest Headlines
Tesaro insiders pledge support for $86M IPO gamble
Tesaro is betting that its management's rep and a late-stage program will help entice investors to snap up 6 million shares at $12 to $15 a share, worth an estimated $86.3 million.
Tesaro promises rapid progress with cancer drugs in $86M IPO
Tesaro has put together an SEC filing that makes one essential promise to prospective investors: This company is built for speed.
